University of Cologne, Center for Integrated Oncology (CIO)
Welcome,         Profile    Billing    Logout  
 3 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cornely, Oliver A
EU-COVAT-1, NCT05160766 / 2021-004526-29: Assessing Immune Response of Different COVID-19 Vaccines in Older Adults

Completed
2
323
Europe
Comirnaty(BTN162b2), BioNTech/ Pfizer, Spikevax (mRNA-1273), Moderna
Oliver Cornely, MD, European Commission, VACCELERATE
Vaccination Reaction, COVID-19, Vaccination; Infection
10/22
09/23
SCYNERGIA, NCT03672292 / 2018-002565-18: Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis

Terminated
2
22
Europe, Canada, US, RoW
SCY-078, Ibrexafungerp, Voriconazole, Oral Placebo Tablets, SCY-078 matching Placebo
Scynexis, Inc., SCYNEXIS, Inc.
Invasive Pulmonary Aspergillosis
03/23
03/23
CandiReg, NCT03450005: ECMM Candida Registry -

Recruiting
N/A
2000
Europe
University of Cologne
Invasive Candidiases
12/25
12/26
Fungiscope, NCT01731353: FungiScope - A Global Emerging Fungal Infection Registry

Recruiting
N/A
1000
Europe
University of Cologne, Pfizer, Basilea Pharmaceutica, Cidara Therapeutics Inc., F2G Biotech GmbH, Matinas Biopharma, Inc
Invasive Fungal Disease
12/26
12/26
NCT04933981: Benefit of Expanded Surveillance of Nursing Homes During the COVID-19 Pandemic

Completed
N/A
1587
Europe
Nasopharyngeal swab for SARS-CoV-2
University of Cologne, City Council of Cologne, Department of Public Health, NRW, Germany, City Council of Cologne, Department of Social Affairs, Health and Environment, NRW, Germany
COVID-19 Respiratory Infection, SARS-CoV-2 Infection
12/20
06/21
A-COV-V, NCT05597761: Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC)

Recruiting
N/A
100
Europe
Oliver Cornely, MD, ZKS Köln, German Federal Ministry of Education and Research
COVID-19, Adult, Immunocompromised Patients
09/25
12/25

Download Options